CHGCY
Price:
$23.78
Market Cap:
$11.93T
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutic...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2012-08-03
Stock Exchange
PNK
Ticker
CHGCY
According to Chugai Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 11.54T. This represents a change of 192.09% compared to the average of 3.95T of the last 4 quarters.
The mean historical Enterprise Value of Chugai Pharmaceutical Co., Ltd. over the last ten years is 2.80T. The current 11.54T Enterprise Value has changed 41.10% with respect to the historical average. Over the past ten years (40 quarters), CHGCY's Enterprise Value was at its highest in in the June 2020 quarter at 9.47T. The Enterprise Value was at its lowest in in the December 2014 quarter at 1.50T.
Average
2.80T
Median
2.71T
Minimum
1.50T
Maximum
4.31T
Discovering the peaks and valleys of Chugai Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 68.04%
Maximum Annual Enterprise Value = 4.31T
Minimum Annual Increase = -34.05%
Minimum Annual Enterprise Value = 1.50T
Year | Enterprise Value | Change |
---|---|---|
2023 | 3.89T | 54.17% |
2022 | 2.52T | -11.25% |
2021 | 2.84T | -34.05% |
2020 | 4.31T | 68.04% |
2019 | 2.57T | -23.20% |
2018 | 3.34T | 11.13% |
2017 | 3.01T | 67.15% |
2016 | 1.80T | -19.15% |
2015 | 2.23T | 48.57% |
2014 | 1.50T | 21.12% |
The current Enterprise Value of Chugai Pharmaceutical Co., Ltd. (CHGCY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
3.09T
5-year avg
3.23T
10-year avg
2.80T
Chugai Pharmaceutical Co., Ltd.’s Enterprise Value is greater than Scilex Holding Company (285.15M), greater than Merck & Co., Inc. (284.66B), greater than Johnson & Johnson (396.75B), greater than Pfizer Inc. (225.71B), greater than Astellas Pharma Inc. (3.73T), greater than Bristol-Myers Squibb Company PFD CONV 2 (154.95B), greater than Otsuka Holdings Co., Ltd. (4.87T), less than Novartis AG (0), greater than AstraZeneca PLC (232.94B), greater than GSK plc (248.09B), greater than Roche Holding AG (54.96B), greater than Bristol-Myers Squibb Company (251.88B), greater than Horizon Therapeutics Public Limited Company (154.32B), greater than Gilead Sciences, Inc. (92.83M), greater than Sanofi (132.43B), greater than null (138.98B),
Company | Enterprise Value | Market cap |
---|---|---|
285.15M | $185.04M | |
284.66B | $258.22B | |
396.75B | $380.98B | |
225.71B | $157.31B | |
3.73T | $19.92B | |
154.95B | $113.09B | |
4.87T | $33.51B | |
0 | $216.23B | |
232.94B | $221.47B | |
248.09B | $75.40B | |
54.96B | $257.13B | |
251.88B | $112.46B | |
154.32B | $0 | |
92.83M | $111.85B | |
132.43B | $132.76B | |
138.98B | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chugai Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Chugai Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Chugai Pharmaceutical Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Chugai Pharmaceutical Co., Ltd. (CHGCY)?
What is the 3-year average Enterprise Value for Chugai Pharmaceutical Co., Ltd. (CHGCY)?
What is the 5-year average Enterprise Value for Chugai Pharmaceutical Co., Ltd. (CHGCY)?
How does the current Enterprise Value for Chugai Pharmaceutical Co., Ltd. (CHGCY) compare to its historical average?